Homology Medicines
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FIXX and buy or sell other stocks, ETFs, and their options commission-free!About FIXX
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives.
CEOJodie P. Morrison
CEOJodie P. Morrison
Employees42
Employees42
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
Founded
Employees42
Employees42
FIXX Key Statistics
Market cap51.43M
Market cap51.43M
Price-Earnings ratio-1.14
Price-Earnings ratio-1.14
Dividend yield—
Dividend yield—
Average volume185.10K
Average volume185.10K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.37
52 Week high$6.37
52 Week low$1.35
52 Week low$1.35
Stock Snapshot
The current Homology Medicines(FIXX) stock price is $4.18, with a market capitalization of 51.43M. The stock trades at a price-to-earnings (P/E) ratio of -1.14.
Homology Medicines(FIXX) stock opened on 2026-01-21 at —. The price climbed to — and dipped to —.
The Homology Medicines(FIXX)'s current trading volume is 0, compared to an average daily volume of 185.1K.
During the past year, Homology Medicines(FIXX) stock moved between $1.35 at its lowest and $6.37 at its peak.
During the past year, Homology Medicines(FIXX) stock moved between $1.35 at its lowest and $6.37 at its peak.
People also own
Based on the portfolios of people who own FIXX. This list is generated using Robinhood data, and it’s not a recommendation.